EMMAUS LIFE SCIENCES, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
EMMAUS LIFE SCIENCES, INC. (EMMA) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $1.10 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.10M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.12M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $6.79M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $6.15M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.12M 10-K · filed 2026-03-31 |
| 2023-12-31 | $6.79M 10-K · filed 2025-04-14 |
| 2022-12-31 | $6.15M 10-K · filed 2024-07-03 |
| 2021-12-31 | $5.96M 10-K · filed 2023-03-31 |
| 2020-12-31 | $5.92M 10-K · filed 2022-03-31 |
| 2019-12-31 | $5.72M 10-K/A · filed 2021-08-10 |
| 2018-12-31 | $6.00M 10-K · filed 2021-01-25 |